Unintended consequences · parents of children aged < 5 years
1 finding from 1 review
Annual rate of change in % predicted FEV1 Subgroup: under 13 years of age · adults and children with cystic fibrosis
1 finding from 1 review
Annual rate of change in % predicted FEV1 Subgroup: over 13 years of age · adults and children with cystic fibrosis
1 finding from 1 review
Annual rate of change in % predicted FVC Subgroup: Under 13 years of age · adults and children with cystic fibrosis
1 finding from 1 review
Annual rate of change in % predicted FVC Subgroup: Over 13 years of age · adults and children with cystic fibrosis
1 finding from 1 review
Death or neurodevelopmental impairment at age 2 to 3 years · babies born preterm, and their mothers
It is very uncertain whether DCC with immediate neonatal care after cord clamping changes death or neurodevelopmental impairment at age 2 to 3 years compared with UCM (very low certainty).
1 finding from 1 review
Death or neurodevelopmental impairment at age 2 to 3 years · babies born preterm, and their mothers
1 finding from 1 review
Death or neurodevelopmental impairment at age 2 to 3 years · babies born preterm, and their mothers
DCC with immediate neonatal care with cord intact may leads to lower death or neurodevelopmental impairment at age 2 to 3 years compared with ECC (low certainty).
1 finding from 1 review
Bayley‐III Cognitive composite score at 2 years of age corrected for prematurity
1 finding from 1 review
Bayley‐III Motor composite score at 2 years of age corrected for prematurity
1 finding from 1 review
Bayley‐III Language composite score at 2 years of age corrected for prematurity
1 finding from 1 review
Intervention not reported
Change in measures of growth and maturation: change in puberty proportion with Tanner stage ≧ 1 level ‐ at 2 years · children with familial hypercholesterolemia
The intervention showed no clear difference in change in measures of growth and maturation: change in puberty… (low certainty).
1 finding from 1 review
Mean height‐for‐age z‐score · children under 5 years old
Nutrition systems strengthening interventions targeting children may leads to higher height‐for‐age (z‐score) at 18 months compared with no intervention or standard care to reduce stunting (height‐for‐age,… (low certainty).
1 finding from 1 review
Stunting · children under 5 years old
1 finding from 1 review
Stunting · children under 5 years old
Micronutrient or macronutrient supplementation interventions in… showed no clear difference in height‐for‐age (z‐score) compared with no intervention, or placebo to reduce stunting (height‐for‐age,… (low certainty).
1 finding from 1 review
Height‐for‐age (z‐score) Length gain (6 months) · children under 5 years old
1 finding from 1 review
Height‐for‐age (%) at 18 months, 21 months Length gain · children under 5 years old
1 finding from 1 review
Resource implications (e.g. cost of incontinence management methods) · children aged 3 to 17 years with daytime urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Resource implications (e.g. cost of incontinence management methods) · children aged 5 to 16 years with daytime urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Resource implications (e.g. cost of incontinence management methods) · children aged 5 to 14 years with overactive bladder and at least one episode of daytime urinary incontinence per week
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found